$3.12
-$0.10
(-3.11%)
Quote as of 4:00 PM EST on 02/10/12
THRESHOLD PHARMACEUTICALS, INC...
NASDAQ:THLD
|
$3.12
-$0.10
(-3.11%)
|
|
| Today's Open | $3.20 |
|---|---|
| Previous Close | $3.22 |
| Daily Range | $2.96 - $3.22 |
| 52-Week Range | $1.18 - $4.08 |
| Market Cap | $153.28M |
| P/E Ratio | -4.95 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,802,126 |
| Average Daily Volume | 1,580,838 |
| Current FY EPS | -$0.60 |
THLD Information
| Description |
|---|
| A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
MKGAF-THLD Unite for Cancer Cure - Analyst Blog
Limit Your Risk: Smart Money Stock Picks in Strong Cash Positions
3 Cancer-Fighting Stocks That Could Deliver Huge Gains
Smart Money Trends: 5 Biotech Stocks Being Bought Up By Insiders and Institutions
Low-Priced Biotech Stocks With Insider Buying
Undervalued Apricus Bio Poised to Follow Threshold Pharma in Receiving SPA Approval
19 High Growth Micro Cap Stocks Under $10
Amgen, Celgene and Novartis in the Fight Against Pancreatic Cancer
